Aizyvia Biotech is a boutique scientific consulting firm focused on accelerating drug discovery with the intelligent use of AI and machine learning. We support pharmaceutical and academic teams by delivering insight-driven, computation-first strategies for faster and more efficient therapeutic development.

Our founder brings over two decades of hands-on expertise in computer-aided drug design (CADD), with a proven track record of contributing to FDA-approved drugs and pipeline assets. From neuroscience to oncology, our work has directly impacted clinical candidates and commercial success stories.